PATENT CLAIM ANALYSIS

Application Number: 15889464
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "456000"]

Abstract:
Methods of using compounds that inhibit soluble epoxide hydrolase (sEH) for the treatment of ocular diseases, and in particular, of wet age-related macular degeneration (AMD), are disclosed herein.

Claim (Index 19):
The method as set forth in  claim 15  comprising administering the sEH inhibitor via eye drops or eye ointment at a dosing regimen selected from the group consisting of once a day and twice a day to the subject.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13698518', '10665203', '14775357', '16341075', '12092346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7261728043950844
- 35 USC 102 Novelty (BERT): 0.4976604344076176
- Combined Prediction Score: 0.7033215673963377
- Mean Citation Score: 196.077932
- Max Citation Score: 218.17787
- Similarity Product: 146.06618118417384

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test